Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
Aging Cell|March 1, 2024
Transcriptomic and intervention evidence reveals domestic dogs as a promising model for anti-inflammatory investigationMin Zeng, Tong Zhou, Zhiyu Li, et al.Aging and Disease|May 13, 2024
Revolutionizing Diabetic Foot Ulcer Care: The Senotherapeutic ApproachGuiqin Zhang, Priyadarshani Nadeeshika Samarawickrama, Li Gui, et al.Aging Cell|June 14, 2023
A rationally designed fluorescence probe achieves highly specific and long-term detection of senescence in vitro and in vivoLi Hu, Chanjuan Dong, Zhe Wang, et al.BMC Medicine|January 31, 2026
Targeting BCL-XL for degradation synergizes with gemcitabine against cholangiocarcinomaQinghua Zeng, Yan Zhang, Yiwen Yang, et al.Aging and Disease|May 10, 2023
Longevity-Associated Transcription Factor ATF7 Promotes Healthspan by Suppressing Cellular Senescence and Systematic InflammationYaqun Huang, Ming-Xia Ge, Yu-Hong Li, et al.Aging Cell|May 17, 2018
Oxidation resistance 1 is a novel senolytic targetXin Zhang, Suping Zhang, Xingui Liu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 29, 2024
Liver-targeting chimeras as a potential modality for the treatment of liver diseasesChuanjie Chen, Yongzhang Pan, Xiaoyu Yang, et al.JCI Insight|September 2, 2020
Osteocyte RANKL is required for cortical bone loss with age and is induced by senescenceHa-Neui Kim, Jinhu Xiong, Ryan S MacLeod, et al.Journal of Hematology & Oncology|July 18, 2020
DT2216-a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomasYonghan He, Raphael Koch, Vivekananda Budamagunta, et al.Nature Aging|January 31, 2025
A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in miceYang Yang, Natacha Jn-Simon, Yonghan He, et al.Pageof 6